Follicular Lymphoma News and Research

Latest Follicular Lymphoma News and Research

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

PerkinElmer to unveil innovative cancer research solutions at AACR meeting

PerkinElmer to unveil innovative cancer research solutions at AACR meeting

Final data from Aeterna Zentaris’ perifosine plus sorafenib Phase 2 study on lymphomas

Final data from Aeterna Zentaris’ perifosine plus sorafenib Phase 2 study on lymphomas

Women respond much better than men to treatment of CFL with rituximab

Women respond much better than men to treatment of CFL with rituximab

Radiation therapy alone no longer the best choice for early follicular lymphoma

Radiation therapy alone no longer the best choice for early follicular lymphoma

FDA requests Biovest to conduct second Phase III trial of BV301 for NHL

FDA requests Biovest to conduct second Phase III trial of BV301 for NHL

Biovest receives Rapporteur and Co-Rapporteur designation for BiovaxID personalized cancer vaccine

Biovest receives Rapporteur and Co-Rapporteur designation for BiovaxID personalized cancer vaccine

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

Diabetes linked to increased blood cancer risk

Diabetes linked to increased blood cancer risk

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

Halozyme first quarter net loss increases to $15.1 million

Halozyme first quarter net loss increases to $15.1 million

ImmunoGen commences IMGN529 Phase I trial in NHL

ImmunoGen commences IMGN529 Phase I trial in NHL

Biovest seeks Health Canada approval of BiovaxID for follicular NHL

Biovest seeks Health Canada approval of BiovaxID for follicular NHL

TL32711 compound targets key pathway in lymphoma

TL32711 compound targets key pathway in lymphoma

Re-treatment with rituximab may benefit patients with LTB follicular lymphoma

Re-treatment with rituximab may benefit patients with LTB follicular lymphoma

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

Cancer Research UK embarks on new initiative to unravel genetic secrets behind cancers

Cancer Research UK embarks on new initiative to unravel genetic secrets behind cancers